Patent ID: 9579281
Date: 2017-02-28
CPC Classifications: A61K,A61P

Claim:
1. A method for treatment of at least one disease selected from the group consisting of dyslipidemia, postprandial hypertriglyceridemia, arteriosclerosis, platelet aggregation, and peripheral circulatory insufficiency, comprising: administering to a subject in need thereof a self-emulsifying composition comprising: a) 50 to 95% by weight in total amount of the self-emulsifying composition of at least one compound selected from the group consisting of ω3 polyunsaturated fatty acids, pharmaceutically acceptable salts and esters thereof; b) 10 to 50 parts by weight of an emulsifier having a hydrophilic lipophilic balance of at least 10 based on 100 parts by weight of said component (a), wherein the emulsifier comprises at least one member selected from the group consisting of polyoxyethylene hydrogenated castor oil, polyoxyethylene sorbitan fatty acid exter, polyoxyethylene castor oil, polyethylene glycol fatty acid ester, polyoxyethylene polyoxypropylene glycol, and sucrose fatty acid ester; c) up to 4% by weight of ethanol in relation to the total amount of the compound; and d) 3 to 40 parts by weight of a lecithin based on 100 parts by weight of component (a).